Abstract Treatment of congenital adrenal hyperplasia (CAH) requires lifelong replacement of
glucocorticoids with regular follow up to manage associated morbidities. The current review …

Congenital adrenal hyperplasia (CAH) is a common disorder of impaired adrenal cortisol
biosynthesis with associated androgen excess. The clinical presentation of 21-hydroxylase …

Congenital adrenal hyperplasia (CAH) is a disorder of adrenal gland cortisol biosynthesis
caused by key enzyme deficiencies, the most common being 21-hydroxylase in 90–95 …

Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive diseases that may
cause cortisol insufficiency together with other hormonal alterations. The most common form …

Much remains to be learned about the optimal management of children with CAH, including
fludrocortisone replacement in simple-virilizing patients, frequency of specific monitoring …

Objectives: To evaluate the growth parameters in congenital adrenal hyperplasia patients in
Jeddah, Saudi Arabia. Methods: This is a descriptive retrospective study over the period of 5 …

Classical congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency leads to
glucocorticoid and mineralocorticoid deficiency. Management should be viewed as a …

Background: Congenital adrenal hyperplasia (CAH) in children varies in presentation and
progression with several challenges in optimal management. Effective treatment is to …

Management of congenital adrenal hyperplasia: beyond convent... : Current Opinion in
Pediatrics Management of congenital adrenal hyperplasia: beyond conventional glucocorticoid …

Background: The standard treatment for congenital adrenal hyperplasia (CAH) in children is
still hydrocortisone. Improved strategies for timing of the dose during the day and the dose …